Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Erythromycin prophylaxis for recurrent otitis media.

R M Lampe, M R Weir

    Clinical Pediatrics
    |October 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Histological Evolution of BK Virus-Associated Nephropathy: Importance of Integrating Clinical and Pathological Findings.

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2017
    Same author

    Efficacy of an amlodipine/olmesartan treatment algorithm in patients with or without type 2 diabetes and hypertension (a secondary analysis of the BP-CRUSH study).

    Journal of human hypertension·2012
    Same author

    Association of serum uric acid with graft survival after kidney transplantation: a time-varying analysis.

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2011
    Same author

    Can the early elimination of calcineurin inhibitors result in clinical benefits?

    Transplantation proceedings·2010
    Same author

    How early should blood pressure control be achieved for optimal cardiovascular outcomes?

    Journal of human hypertension·2010
    Same author

    Efficacy, safety and tolerability of aliskiren, a direct renin inhibitor, in women with hypertension: a pooled analysis of eight studies.

    Journal of human hypertension·2010
    Same journal

    Effect of Preferred Language on Pediatric Rapid Response Activation and Subsequent Intensive Care Utilization.

    Clinical pediatrics·2026
    Same journal

    Documented Caregiver Report of Wheezing at Home is Associated With Decreased Length of Pediatric Asthma Hospitalizations.

    Clinical pediatrics·2026
    Same journal

    The Rash That Will Not Go Away.

    Clinical pediatrics·2026
    Same journal

    Virtual Reality Education for Hospitalized Pediatric Patients Improves Intrinsic Motivation: A Prospective, Randomized Crossover Study.

    Clinical pediatrics·2026
    Same journal

    Pediatric Invasive Group A Streptococcus Characteristics Before, During, and After COVID-19.

    Clinical pediatrics·2026
    Same journal

    Lichen Sclerosus: A Common but Often Overlooked Condition in Pediatric Patients.

    Clinical pediatrics·2026
    See all related articles

    Erythromycin prophylaxis significantly reduced recurrent otitis media in children. This antibiotic was more effective than sulfisoxazole or no treatment for preventing ear infections in this patient group.

    Area of Science:

    • Pediatrics
    • Infectious Diseases
    • Pharmacology

    Background:

    • Recurrent otitis media is a common childhood illness.
    • Effective antibiotic prophylaxis strategies are needed to reduce infection rates.

    Purpose of the Study:

    • To evaluate the efficacy of erythromycin ethylsuccinate and sulfisoxazole as prophylactic agents for recurrent otitis media in children without persistent middle ear effusion.

    Main Methods:

    • A two-phase study involving children with recurrent otitis media.
    • Phase 1: Erythromycin ethylsuccinate prophylaxis (10 mg/kg twice daily).
    • Phase 2: Comparison of erythromycin with sulfisoxazole (500 mg twice daily) and no prophylaxis.

    Main Results:

    • Erythromycin prophylaxis reduced the attack rate of acute otitis media from 0.86 to 0.20 episodes per 2 months.

    Related Experiment Videos

  • Erythromycin (18% incidence) was more effective than sulfisoxazole (51% incidence) and no prophylaxis (43% incidence).
  • Sulfisoxazole prophylaxis showed no significant benefit over no prophylaxis.

    • Conclusions:

    • Erythromycin antimicrobial prophylaxis is superior to no prophylaxis and sulfisoxazole prophylaxis for children experiencing recurrent otitis media without persistent middle ear effusion.